Fontan-Associated Liver Disease: A Review

被引:52
作者
Tellez, Luis [1 ]
Rodriguez-Santiago, Enrique [1 ]
Albillos, Agustin [1 ]
机构
[1] Univ Alcala, Hosp Univ Ramon & Cajal, Ctr Invest Biomed Red Area Enfermedades Digest CI, Serv Gastroenterol & Hepatol,IRYCIS, Madrid, Spain
关键词
Fontan surgery; Liver disease; Hepatocarcinoma; Ascites; Fontan failure; HEPATOCELLULAR-CARCINOMA; HEPATIC-FIBROSIS; ADULT PATIENTS; PORTAL-HYPERTENSION; CARDIAC CIRRHOSIS; LONG-TERM; MELD-XI; CIRCULATION; OPERATION; PATHOLOGY;
D O I
10.5604/01.3001.0010.8634
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Fontan-associated liver disease is a hepatic disorder arising from hemodynamic changes and systemic venous congestion following Fontan surgery. The histological changes produced in the liver are similar but not equivalent to those seen in other forms of cardiac liver disease. While the natural history of this form of liver disease is not well established, over time many Fontan patients develop portal hypertension-related complications such as ascites, variceal hemorrhage or encephalopathy. Fontan survivors also show an increased risk of hepatocellular carcinoma. Early diagnosis of advanced liver disease is mandatory for the prevention and treatment of complications such as hepatocellular carcinoma, esophageal varices and malnutrition. This review updates current knowledge of the pathophysiology and management of Fontan-associated liver disease including new diagnostic methods and treatments.
引用
收藏
页码:192 / 204
页数:13
相关论文
共 79 条
  • [1] Fontan circulation causes early, severe liver damage. Should we offer patients a tailored strategy?
    Agnoletti, Gabriella
    Ferraro, Gaetana
    Bordese, Roberto
    Marini, Davide
    Gala, Simona
    Bergamasco, Laura
    Ferroni, Francesca
    Calvo, Pier Luigi
    Barletti, Claudio
    Cisaro, Fabio
    Longo, Filomena
    Napoleone, Carlo Pace
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 209 : 60 - 65
  • [2] Allen KY, 2017, J THORAC CARDIOVASC, V154
  • [3] Amer Assoc Study Liver Dis, 2014, J HEPATOL, V61, P642, DOI 10.1016/j.jhep.2014.05.042
  • [4] Nephropathy in patients after Fontan palliation
    Anne, Premchand
    Du, Wei
    Mattoo, Tej K.
    Zilberman, Mark V.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 132 (02) : 244 - 247
  • [5] Hepatocellular Carcinoma after the Fontan Procedure
    Asrani, Sumeet K.
    Warnes, Carole A.
    Kamath, Patrick S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (18) : 1756 - 1757
  • [6] Congenital heart disease and the liver
    Asrani, Sumeet K.
    Asrani, Nina S.
    Freese, Deborah K.
    Phillips, Sabrina D.
    Warnes, Carole A.
    Heimbach, Julie
    Kamath, Patrick S.
    [J]. HEPATOLOGY, 2012, 56 (03) : 1160 - 1169
  • [7] Fontan-associated liver disease: Spectrum of US findings
    Bae, Jung Min
    Jeon, Tae Yeon
    Kim, Jung Sun
    Kim, Seokhwi
    Hwang, Sook Min
    Yoo, Young
    Kim, Ji Hye
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2016, 85 (04) : 850 - 856
  • [8] Late hepatic complications after Fontan operation; non-invasive markers of hepatic fibrosis and risk factors
    Baek, Jae Suk
    Bae, Eun Jung
    Ko, Jae Sung
    Kim, Gi Beom
    Kwon, Bo Sang
    Lee, Sang Yun
    Noh, Chung Il
    Park, Eun-Ah
    Lee, Whal
    [J]. HEART, 2010, 96 (21) : 1750 - 1755
  • [9] BALAJI S, 1991, CIRCULATION, V84, P162
  • [10] Berzigotti A, 2011, DIS MARKERS, V31, P129, DOI [10.1155/2011/954812, 10.3233/DMA-2011-0835]